Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Indivior plc
Current Parent CompanyIndivior PLC
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $300,000,000
Year: 2021
Date: April 27, 2021
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Secondary Offense: opioid crisis litigation
Mega-ScandalOpioid Crisis
Violation Description: Indivior agreed to pay over $300 million to state governments to resolve allegations that it falsely and aggressively marketed Suboxone, resulting in improper use of state Medicaid funds. Suboxone is a drug product approved for use by recovering opioid addicts to avoid or reduce withdrawal symptoms while they undergo treatment.
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: United Kingdom
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: specialty pharmaceuticals
Source of Data(click here)
Link to Archived Court Document subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.